Health / Health News |
New MRI method provides detailed view of the placenta during pregnancy
Researchers have developed a new method to process MRI scans to reveal the distinct compartments of the placenta, take measurements of oxygen levels in each region and determine if there are malformations in blood vessels (i.e., placental lesions).
The study team, led by Yong Wang, Ph.D., at Washington University in St. Louis and Alison Cahill, M.D., at the University of Texas at Austin, developed analysis methods for MRI scans that are routinely collected in hospitals and healthcare facilities.
Importantly, these types of MRI scans do not require contrast agents, which are only used during pregnancy for limited circumstances.
The team’s machine learning method automatically processes MRI data to visualize separate placental compartments, including the intervillous space (the area where maternal blood enters to provide nutrients and gas exchange), placental vessels and placental tissue.
Unlike current MRI analysis methods, which can only measure placental oxygen as an average across the entire organ, the new method can characterize oxygen levels within these discrete compartments.
The study team also used these region-specific measurements to look for differences between 22 study participants with healthy pregnancies and five participants who went on to develop pregnancy complications.
While they did observe trends — highlighting the potential for this technique to detect specific pregnancy complications — further analysis is needed among larger groups of study participants.
Overall, the new method can serve as an objective, quantitative method to assess placental health during pregnancy.
With additional validation and refinement of this technique, the method may be used by healthcare providers as a tool in the care of pregnant patients, especially those at risk for pregnancy complications.
Early monitoring of the placenta can lead to better detection and prevention of pregnancy complications, including preterm birth, fetal growth disorders and preeclampsia. (National Institutes of Health)